Structural investigation of the A domains of human blood coagulation factor V by molecular modeling

Protein Science

Volumn 7, Issue 6, 1998, Pages 1317-1325

  Villoutreix, Bruno O ^a,b   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APC resistance; Blood coagulation; Factor V; Protein modeling; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; CALCIUM; CERULOPLASMIN; COPPER; LEUKOCYTE ELASTASE; PROTEIN S; PROTHROMBIN; THROMBIN;

ARTICLE; BINDING SITE; BLOOD CLOTTING; GENE MUTATION; HUMAN; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

EID: 2642679231     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070607     Document Type: Article

References (95)

1. Adman ET. 1991. Copper protein structures. Adv Prot Chem 42:145-197.
2. Adman ET, Stenkamp RE, Sieker LC, Jensen LH. 1978. A crystallographic model for azurin at 3 Å resolution. J Mol Biol 123:35-47.
3. Annamalai AE, Rao AK, Chiu HC, Wang D, Dutta Roy AK, Walsh PN, Colman RW. 1987. Epitope mapping of functional domains of human factor Va with human and murine monoclonal antibodies. Evidence for interaction of heavy chain with factor Xa and calcium. Blood 70:139-146.
4. Aparicio C, Dahlbäck B. 1996. Molecular mechanisms of activated protein C resistance. Biochem J 313:467-472.
5. Bakker HM, Tans G, Janssen Claessen T, Thomassen MCLGD, Hemker HC, Griffin JH, Rosing J. 1992. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 208:171-178.
6. Bakker HM, Tans G, Thomassen MCLGD, Yukelson LY, Ebberink R, Hemker HC, Rosing J. 1994. Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chain. J Biol Chem 269:20662-20667.
7. Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasmui M. 1977. The protein data bank: A computer-based archival file for macromolecular structures. J Mol Biol 112:535-542.
8. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH. 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67.
9. Bihoreau N, Pin S, de Kersabiec A-M, Vidot F, Fontaine-Aupart M-P. 1994. Copper atom identification in the active and inactive forms of plasma-derived FVIII and recombinant FVIII-ΔII. Eur J Biochem 222:41-48.
10. Bloom JW, Nesheim ME, Mann KG. 1979. Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry 18:4419-4425.
11. Bode W, Huber R. 1991. Ligand binding: Proteinase-protein inhibitor interactions. Curr Opin Struct Biol 1:45-52.
12. Colman PM, Freeman HC, Guss JM, Murata M, Norris VM, Ramshaw JAM, Venkatappa MP. 1978. X-ray crystallographic structure analysis of plastocyanin at 2.7 Å resolution. Nature 272:319-324.
13. Dahlbäck B. 1986. Bovine coagulation factor V visualized with electron microscopy. J Biol Chem 261:9495-9501.
14. Dahlbäck B. 1997. Resistance to activated protein C as risk factor for thrombosis: Molecular mechanisms, laboratory investigation and clinical management. Seminars in Hematology 34:217-234.
15. Dahlbäck B, Carlsson M, Svensson PJ. 1993. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004-1008.
16. Dahlbäck B, Hildebrand B. 1994. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 94:1396-1400.
17. Dahlbäck B, Stenflo J. 1980. The activation of prothrombin by platelet-bound factor Xa. Eur J Biochem 104:549-557.
18. Dahlbäck B, Stenflo J. 1994. The protein C anticoagulant system. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The molecular basis of blood diseases. Philadelphia, PA: W.B. Saunders. pp 599-628.
19. Egan JO, Kalafatis M, Mann KG. 1997. The effect of Arg306 → Ala and Arg506 → Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. Protein Sci 6:2016-2027.
20. Fay PJ, Beattie T, Huggins CF, Regan LM. 1994. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem 269:20522-20527.
21. Fay PJ, Smudzin TM. 1989. Intersubunit fluorescence energy transfer in human factor VIII. J Biol Chem 264:14005-14010.
22. Fay PJ, Smudzin TM, Walker FJ. 1991. Activated protein C-catalysed inactivation of human factor VIII and factor VIIIa. J Biol Chem 266:20139-20145.
23. Fowler WE, Fay PJ, Arvan DS, Marder VJ. 1990. Electron microscopy of human factor V and factor VIII: Correlation of morphology with domain structure and localization of factor V activation fragments. Proc Natl Acad Sci USA 87:7648-7652.
24. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. 1994. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343:1361-1362.
25. Greer J. 1990. Comparative modeling methods: Application to the family of the mammalian serine proteases. Proteins 7:317-334.
26. Guinto ER, Esmon CT. 1982. Formation of a calcium-binding site on bovine activated factor V following recombination of the isolated subunits. J Biol Chem 257:10038-10043.
27. Guinto ER, Esmon CT. 1984. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. J Biol Chem 259:13986-113992.
28. Guinto ER, Esmon CT, Mann KG, MacGillivray RT. 1992. The complete cDNA sequence of bovine coagulation factor V. J Biol Chem 267:2971-2978.
29. Heeb MJ, Kojima Y, Hackeng TM, Griffin JH. 1996. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va. Protein Sci 5:1883-1889.
30. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. 1993. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 268:2872-2877.
31. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. 1994. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 91:2728-2732.
32. Hibbard LS, Mann KG. 1980. The calcium binding properties of bovine factor V. J Biol Chem 255:638-645.
33. Hobohm U, Sander C. 1994. Enlarged representative set of protein structures. Protein Sci 3:522-524.
34. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG. 1987. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 84:4846-4850.
35. Jenny RJ, Tracy PB, Mann KG. 1994. The physiology and biochemistry of factor V. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds. Haemostasis and thrombosis. New York: Churchill Livingstone. pp 465-476.
36. Jones T, Thirup S. 1986. Using known substructures in protein model building and crystallography. EMBO J 5:819-822.
37. Kalafatis M, Bertina RM, Rand MD, Mann KG. 1995. Characterization of the molecular defect in factor VR506Q. J Biol Chem 270:4053-4057.
38. Kalafatis M, Jenny RJ, Mann KG. 1990. Identification and characterization of a phopholipid-binding site of bovine factor Va. J Biol Chem 265:21580-21589.
39. Kalafatis M, Rand MD, Mann KG. 1994a. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry 33:486-493.
40. Kalafatis M, Rand MD, Mann KG. 1994b. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869-31880.
41. Kalafatis M, Xue J, Lawler CM, Mann KG. 1994c. Contribution of the heavy and light chains of factor Va to the interaction with factor Xa. Biochemistry 33:6538-6545.
42. Kane WH, Davie EW. 1986. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci USA 83:6800-6804.
43. Kane WH, Ichinose A, Hagen FS, Davie EW. 1987. Cloning of cDNA's coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 26:6508-6514.
44. Kisiel W, Canfield WM, Ericsson LH, Davie EW. 1977. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 16:5824-5831.
45. Koppaka V, Talbot WF, Zhai X, Lentz BR. 1997. Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex. Biophys J 73:2638-2652.
46. Krishnaswamy S, Mann KG. 1988. The binding of factor Va to phospholipid vesicles. J Biol Chem 263:5714-5723.
47. Krishnaswamy S, Williams EB, Mann KG. 1986. The binding of activated protein C to factors V and Va. J Biol Chem 261:9684-9693.
48. Lampe PD, Wei GJ, Pusey ML, Nelsestuen GL. 1984. Electron microscopy and hydrodynamic properties of blood clotting factor V and activation fragments of factor V with phospholipid vesicles. J Biol Chem 259:9959-9964.
49. Lee B, Richards FM. 1971. The interpretation of protein structure: estimation of static accessibility. J Mol Biol 55:379-400.
50. Lenting PJ, Van de Loo JWHP, Donath MJSH, Van Mourik JA, Mertens K. 1996. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. J Biol Chem 271:1935-1940.
51. Lollar P, Parker C. 1990. pH-Dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem 265:1688-1692.
52. Lu D, Kalafatis M, Mann KG, Long GL. 1996. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood 87:4708-4717.
53. Luckow EA, Lyons DA, Ridgeway TM, Esmon CT, Laue TM. 1989. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: Analysis by analytical ultracentrifugation. Biochemistry 28:2348-2354.
54. Mann KG, Hockin MF, Begin KJ, Kalafatis M. 1997. Activated protein C cleavage of factor Va leads to dissociation of the A2 domain. J Biol Chem 272:20678-20683.
55. Mann KG, Lawler CM, Vehar GA, Church WR. 1984. Coagulation factor V contains copper ion. J Biol Chem 259:12949-12951.
56. Mather T, Oganessyan V, Hof P, Huber R, Foundling S, Esmon C, Bode W. 1996. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J 15:6822-6831.
57. Mosesson MW, Church WR, DiOrio JP, Krishnaswamy Sriram, Mann KG, Hainfeld JF, Wall JS. 1990. Structural model of factors V and Va based on scanning transmission electron microscope images and mass analysis. J Biol Chem 265:8863-8868.
58. Murphy MEP, Lindley PF, Adman ET. 1997. Structural comparison of cupredoxin domains: Domain recycling to construct proteins with novel functions. Protein Sci 6:761-770.
59. Murray JM, Rand MD, Egan JO, Murphy S, Kim HC, Mann KG. 1995. Factor Vnew Brunswick: Ala221-to-Va1 substitution results in reduced cofactor activity. Blood 86:1820-1827.
60. Mutucumarana VP, Duffy EJ, Lollar P, Johnson AE. 1992. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study. J Biol Chem 267:17012-17021.
61. Nesheim ME, Taswell JB, Mann KG. 1979. The contribution of bovine factor V and Va to the activity of prothrombinase. J Biol Chem 254:10952-10962.
62. Nicolaes GA, Tans G, Thomassen MCLGD, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J. 1995. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 270:21158-21166.
63. Ortel TL, Devore Carter D, Quinn Allen M, Kane WH. 1992. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J Biol Chem 267:4189-4198.
64. Ortel TL, Quinn Allen M, Keller FG, Peterson JA, Larocca D, Kane WH. 1994. Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras. J Biol Chem 269:15898-15905.
65. Pan Y, DeFay T, Gitschier J, Cohen FE. 1995. Proposed structure of the A domains of factor VIII by homology modelling. Nature Struct Biol 2:740-744.
66. Pemberton S, Lindley P, Zaitsev V, Card G, Tuddenham EGD, Kemball-Cook G. 1997. A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood 89:2413-2421.
67. Ponder JW, Richards FM. 1987. Tertiary templates for proteins: Use of packing criteria in the enumeration of allowed sequences for different structural classes. J Mol Biol 193:775-791.
68. Pusey ML, Mayer LD, Wei GJ, Bloomfield VA, Nelsestuen GL. 1982. Kinetic and hydrodynamic analysis of blood clotting factor V-membrane binding. Biochemistry 21:5262-5269.
69. Pusey ML, Nelsestuen GL. 1984. Membrane binding properties of blood coagulation factor V and derived peptides. Biochemistry 23:6202-6210.
70. Rosing J, Hoekema L, Nicolaes GAF, Thomassen MCLGD, Hemker HC, Varadi K, Schwarz HP, Tans G. 1995. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 270:27852-27858.
71. Rosing J, Tans G. 1997. Coagulation factor V: An old star shines again. Thromb Haemost 78:427-433.
72. Rosing J, Tans G, Govers-Riemslag JWP, Zwaal RFA, Hemker HC. 1980. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 255:274-283.
73. Rost B, Sander C. 1993. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 232:584-599.
74. Sabharwal AK, Padmanabhan K, Tulinsky A, Mathur A, Gorka J, Bajaj SP. 1997. Interaction of calcium with native and decarboxylated human factor X. J Biol Chem 272:22037-22045.
75. Samis JA, Garrett M, Manuel RP, Nesheim ME, Giles AR. 1997. Human neutrophil elastase activates human factor V but inactivates thrombin activated human factor V. Blood 90:1065-1074.
76. Schechter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27:157-162.
77. Shen L, Dahlbäck B. 1994. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 269:18735-18738.
78. Solymoss S, Tucker MM, Tracy PB. 1988. Kinetics of inactivation of membrane-bound factor Va by activated protein C. J Biol Chem 263:14884-14890.
79. Stoylova S, Mann KG, Brisson A. 1994. Structure of membrane-bound human factor Va. FEBS Lett 351:330-334.
80. Suzuki K, Dahlbäck B, Stenflo J. 1982. Thrombin catalyzed activation of human coagulation factor V. J Biol Chem 257:6556-6564.
81. Tagliavacca L, Moon N, Dunham WR, Kaufman RJ. 1997. Identification and functional requirement of Cu(I) and its ligands within coagulation factor VIII. J Biol Chem 272:27428-27434.
82. Takahashi N, Ortel TL, Putnam FW. 1984. Single chain structure of human ceruloplasmin. The complete amino acid sequence of the whole molecule. Proc Natl Acad Sci USA 81:390-394.
83. Thorelli E, Kaufman RJ, Dahlbäck B. 1997. Cleavage requirements for activation of factor V by factor Xa. Eur J Biochem 247:12-20.
84. Tucker MM, Foster WB, Katzmann JA, Mann KG. 1983. A monoclonal antibody which inhibits the factor Va:factor Xa interaction. J Biol Chem 258:1210-1214.
85. van Rijn JLML, Govers Riemslag JWP, Zwaal RFA, Rosing J. 1984. Kinetic studies of prothrombin activation: Effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry 23:4557-4563.
86. van de Waart P, Bruls H, Hemker HC, Lindhout T. 1983. Interaction of bovine blood clotting factor Va and its subunits with phopholipid vesicles. Biochemistry 22:2427-2432.
87. van de Waart P, Hemker HC, Lindhout T. 1984. Interaction of prothrombin with factor Va-phopholipid complexes. Biochemistry 23:2838-2842.
88. Varadi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. 1996. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: Influence of the factor VR506Q mutation. Thromb Haemost 76:208-214.
89. Voorberg J, Roelse JC, Koopman R, Buller HR, Berends F, Ten Cate JW, Mertens K, Van Mourik JA. 1994. Association of idiopathic venous thromboembolism with single point mutation at Arg506 of factor V. Lancet 343:1535-1536.
90. Walker FJ, Scandella D, Fay PJ. 1990. Identification of the binding site for activated protein C on the light chain of factors V and VIII. J Biol Chem 265:1484-1489.
91. Wei A, Rubin H, Cooperman BS, Christianson DW. 1994. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop. Structural Bio 1:251-258.
92. Xue J, Kalafatis M, Silveira JR, Kung C, Mann KG. 1994. Determination of the disulfide bridges in factor Va heavy chain. Biochemistry 33:13109-13116.
93. Yegneswaran S, Wood GM, Esmon CT, Johnson AE. 1997. Protein S alters the active site location of activated protein C above the membrane surface. J Biol Chem 272:25013-25021.
94. Zaitseva I, Zaitsev V, Card G, Moshkov K, Bax B, Ralph A, Lindley P. 1996. The X-ray structure of human serum ceruloplasmin at 3.1 Å: Nature of the copper centres. J Biol Inorg Chem 1:15-23.
95. Zöller B, Dahlbäck B. 1994. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536-1538.